<DOC>
	<DOCNO>NCT00264316</DOCNO>
	<brief_summary>The benefit reperfusion therapies ST-elevation acute myocardial infarction ( STEMI ) limit postinfarction leave ventricular ( LV ) dysfunction.The purpose study determine whether intracoronary transfer bone marrow cell augment leave ventricular function recovery heart .</brief_summary>
	<brief_title>Bone Marrow-Derived Stem Cell Transfer Acute Myocardial Infarctions</brief_title>
	<detailed_description>Despite early coronary reperfusion , salvage ischemic myocardium incomplete loss viable myocardium initiate process adverse left ventricular ( LV ) remodeling1 , compromise clinical outcome . Experimental data suggest autologous bone marrow-derived circulating progenitor cell may beneficial LV function recovery , underlie mechanism unclear prominent cardiomyocyte transdifferentiation report selected experimental condition . Early non-randomized clinical investigation indicate feasibility , safety enhance functional recovery autologous human bone marrow-derived stem cell ( BMSC ) infusion infarct-related artery . More recently , randomize open study demonstrate improvement LV systolic function LV remodel follow BMSC transfer . In absence trial , control group reproduce exact condition cell transfer group , include bone marrow aspiration placebo intracoronary injection , true benefit cell transfer fully appreciate . We , therefore , design randomize , double-blind , placebo-controlled exploratory study investigate effect autologous BMSC transfer LV functional structural recovery myocardial infarction . In view exploratory nature study detect potential mechanism biological effect , also assess myocardial perfusion oxidative metabolism use serial 1- [ 11C ] acetate positron emission tomography ( PET ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>patient acute myocardial infarction cumulative STsegment elevation &gt; =6mm , successful epicardial reperfusion PCI significant LV dysfunction patient present within 2 hour symptom onset ( dilution treatment effect abort infarction ) patient prior coronary artery bypass grafting , pulmonary edema , cardiogenic shock significant comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>bone marrow cell transfer</keyword>
	<keyword>acute myocardial infarction</keyword>
	<keyword>leave ventricular function</keyword>
</DOC>